Tikosyn / Dofetilide: Overview

Modified on 2009/10/14 21:32 by admin
Tikosyn, also known as Dofetilide, is a medicine that is given to patients with irregular heartbeats (atrial fibrillation). Tikosyn may help the heart beat more regularly and stay beating regularly for a longer period of time. A selective potassium channel blocker, Tikosyn effectively maintains normal sinus rhythm in patients. The medication was approved in 1999 and is made by Pfizer Inc.

Side effects of Tikosyn use include, but may not be limited to, headache, chest pain and dizziness. A black box warning on the packaging label indicates that Tikosyn use has been linked to torsades de pointes and QT interval prolongation. Upon Tikosyn initiation, patients should be placed for a minimum of three days in a facility properly trained in electrocardiographic monitoring and cardiac resuscitation. Tikosyn is available to hospitals and prescribers who have undergone appropriate treatment initiation education.

If you have experienced serious health problems after taking Tikosyn, it may be important to contact an attorney who can help you protect your legal rights. Please keep in mind that there may be time limits within which you must commence suit.

See Also

  1. Heart Failure Drugs: Overview
  2. Balance Problems: Overview
  3. Headaches
  4. QT Interval: Overview
  5. Torsades de Pointes: Overview
  Name Size